得克萨斯大学研究人员确定抗体SC27能够消除所有已知的SARS-CoV-2变异物和相关的冠状病毒。 University of Texas researchers identify antibody SC27 capable of neutralizing all known SARS-CoV-2 variants and related coronaviruses.

奥斯汀得克萨斯大学的研究人员已经确定了一种抗体,SC27,能够消除所有已知的SARS-CoV-2变异物和相关的冠状病毒。 Researchers at the University of Texas at Austin have identified an antibody, SC27, capable of neutralizing all known SARS-CoV-2 variants and related coronaviruses. 与单一患者隔离的SC27显示,今后COVID-19治疗的前景良好。 Isolated from a single patient, SC27 shows promise for future COVID-19 treatments. 该小组已申请专利,并正在探索一种通用疫苗,以加强对迅速突变病毒的免疫反应。 The team has filed a patent and is exploring a universal vaccine to enhance immune response against rapidly mutating viruses. 随着美国COVID-19案件上升,这一发现尤其相关。 This discovery is particularly relevant as COVID-19 cases rise in the U.S.